BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37858067)

  • 1. Overexpression of SH2D1A promotes cancer progression and is associated with immune cell infiltration in hepatocellular carcinoma via bioinformatics and in vitro study.
    Xiang QM; Jiang N; Liu YF; Wang YB; Mu DA; Liu R; Sun LY; Zhang W; Guo Q; Li K
    BMC Cancer; 2023 Oct; 23(1):1005. PubMed ID: 37858067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma.
    Ge PL; Li SF; Wang WW; Li CB; Fu YB; Feng ZK; Li L; Zhang G; Gao ZQ; Dang XW; Wu Y
    Aging (Albany NY); 2020 Mar; 12(6):5479-5499. PubMed ID: 32213661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Biomarkers Related to Immune Cell Infiltration in Hepatocellular Carcinoma Using Gene Co-Expression Network.
    Zhou W; Chen Y; Luo R; Li Z; Jiang G; Ou X
    Pathol Oncol Res; 2021; 27():601693. PubMed ID: 34257558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma.
    Xu JH; Guan YJ; Qiu ZD; Zhang X; Zi LL; Zhou Y; Chen C; Yu J; Zhang YC; Wang WX
    Oxid Med Cell Longev; 2021; 2021():6485871. PubMed ID: 34795841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
    Front Immunol; 2021; 12():653836. PubMed ID: 33897701
    [No Abstract]   [Full Text] [Related]  

  • 6. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIGU promotes hepatocellular carcinoma progression through activating NF-κB pathway and increasing immune escape.
    Wei X; Yang W; Zhang F; Cheng F; Rao J; Lu L
    Life Sci; 2020 Nov; 260():118476. PubMed ID: 32971102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
    Yu ZL; Zhu ZM
    Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of hepatocellular carcinoma (HCC).
    Li M; Li H; Zhou C; Li X; Gong J; Chen C; Zhang Y
    Medicine (Baltimore); 2021 Oct; 100(39):e27332. PubMed ID: 34596136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin-Dependent Kinase 4 is expected to be a therapeutic target for hepatocellular carcinoma metastasis using integrated bioinformatic analysis.
    Zhang JN; Wei F; Lei LH; Yang Y; Yang Y; Zhou WP
    Bioengineered; 2021 Dec; 12(2):11728-11739. PubMed ID: 34784846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J
    Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key Genes Associated with Tumor-Infiltrating Non-regulatory CD4- and CD8-Positive T Cells in Microenvironment of Hepatocellular Carcinoma.
    Zhao Z; Wang C; Chu P; Lu X
    Biochem Genet; 2022 Oct; 60(5):1762-1780. PubMed ID: 35092558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
    Xu H; Xiong C; Chen Y; Zhang C; Bai D
    Bioengineered; 2021 Dec; 12(1):2664-2675. PubMed ID: 34115569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
    Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
    EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.
    Zhang M; Pang HJ; Zhao W; Li YF; Yan LX; Dong ZY; He XF
    BMC Cancer; 2018 May; 18(1):511. PubMed ID: 29720116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.
    Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B4GALNT1 promotes carcinogenesis by regulating epithelial-mesenchymal transition in hepatocellular carcinoma based on pan-cancer analysis.
    Liu W; Chen Y; Yang J; Guo M; Wang L
    J Gene Med; 2023 Nov; 25(11):e3552. PubMed ID: 37337736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
    Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
    Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
    Tan W; Peng S; Li Z; Zhang R; Xiao Y; Chen X; Zhu J; Li B; Lv X
    Comput Math Methods Med; 2022; 2022():2021613. PubMed ID: 35069777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.